GGrantScoutHQFind grants
← Back to grants

Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)

National Institutes of Health

The Institutional Development Awards (IDeA) program supports biomedical research capacity building in states that have historically received low levels of NIH funding. The Centers of Biomedical Research Excellence: Development Phase (COBRE-D) program supports institutions in IDeA states to increase

Funding
Varies
Category
Health & Medical
Status
OPEN
Deadline
5/27/2029

About

The Institutional Development Awards (IDeA) program supports biomedical research capacity building in states that have historically received low levels of NIH funding. The Centers of Biomedical Research Excellence: Development Phase (COBRE-D) program supports institutions in IDeA states to increase their biomedical research capacity in a broad scientific area of strategic importance to them but for which they have limited existing infrastructure or expertise.COBRE-D supports a long-term institutional vision focused on the recruitment and mentoring of early-career investigators with supplemental start-up packages for new hires, the establishment of research facilities, and enhancement of research administration support services. This program serves as an on-ramp for less-resourced institutions to the Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) program. This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered.

Eligibility

Eligibility is restricted to institutions that meet the following criteria:Are located in an IDeA-eligible state, commonwealth, or jurisdiction, which are Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Puerto Rico, Rhode Island, South Carolina, South Dakota, Vermont, West Virginia, and Wyoming; andAward doctoral degrees in the health-related sciences or are independent biomedical research institutes/medical centers with ongoing biomedical research programs funded by the NIH or other federal agencies.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Note:Unfunded foreign components are allowed with prior approval.An unfunded foreign component would be a collaboration with investigators at a foreign site anticipated to result in co-authorship, when no IDeA funds are transferred via subcontract to an institution in a foreign country. Please also see NOT-OD-26-084.Foreign PIs or organizations may use center resources as a fee-for-service.In such cases, resulting publications cannot cite or acknowledge NIH grant support.

Applicant types

Continue researching

Related current grants

All Health & Medical grants →

Tribal Management Grant (TMG) Program

Indian Health Service

The Tribal Management Grant program aims to prepare tribes and tribal organizations for assuming all or part of existing Indian Health Service programs functions services and activities under the Public Law 93 638 Indian Self Determination and Education Assistance Act as amended and to further devel

Improving The Capacity of Tribal Communities to Identify Emerging Drug Threats

Office of National Drug Control Policy

This project would fund researchers to address key impediments or challenges that Tribal communities face related to their capacity to identify emerging drug threats and conduct a pilot project to help these communities improve their capacity to detect and respond to emerging drug threats.

Nonfatal Overdoses in Emergency Departments: Bridging Patient Characteristics, Biospecimen Toxicology, and Drug Supply Composition

Office of National Drug Control Policy

This research project will help build local and national drug consumption surveillance, identify gaps in existing drug testing protocols, facilitate information exchange across public health and public safety organizations, and help coordinate an informed response to address the drug crisis.

Pediatric Disaster Care Centers of Excellence Program Cooperative Agreement

Assistant Secretary for Preparedness and Response

The purpose of this NOFO is to fund four PEDs COEs to:Develop a coordinated pediatric disaster care capability for pediatric patient care in disasters.Strengthen pediatric disaster preparedness plans and health care system coordination related to pediatric medical surge in disasters.Enhance statewid